Table 1.
Reference | Age (years)/Sex | COVID-19 infection severitya/Treatment | Delay between COVID-19 and arthritis (days)/RT-PCR at onset of arthritis | Involved joints/Associate signs | Inflam- Matory Biomarkers | Immunological tests | HLA genotyping | Arthritis management | Outcome |
---|---|---|---|---|---|---|---|---|---|
Liew et al. [15] | 47/Male | Asymptomatic/None | 6/Positive | Right knee/Balanitis | N.S | N.S | N.S | NSAIDs IASI | N.S |
Schenker et al. [16] | 65/Female | Moderate/NS | 10/Negative | Ankles, wrists and knee joints/Purpura of the calves | CRP: 34.7 mg/L | FR, ACPA and ANA negative | HLA-B27: positive | Prednisolone | Recovered |
Saricaoglu et al. [17] | 73/Male | Moderate/Ceftriaxone Hidroxychloroquine Azitromycin | 8/Negative | Toes dactylitis | CRP:25 mg/L | RF and ACPA negative | N.S | NSAIDs | Symptoms resolution after 22 days of NSAIDs |
Ono et al. [18] | 50/Male | Critical/Favipiravir cefepime vancomycin | 21/NS | Ankles Calcaneal enthesitis | CRP: 7.4 mg/dL | Negative | HLA -B27:negative | NSAIDs IASI | Moderate improvement |
Sureja et al. [19] | 27/Female | Moderate/Methylprednisolone Favipiravir | 14/Negative | Knees, ankles, midfoot joints, small joints of the right hand | N.S | RF: positive in low titres. ACPA and ANA: negative | HLA-B27: negative | NSAIDs Opioid analgesic. Steroid | Recovered within 3 weeks |
Honge et al.[20] | 53/male | Severe/dexamethasone | 16/Negative | Right knee and ankles | CRP: 327 mg/L | RF, ACPA, AAN: negative | HLA-B27: negative | NSAIDs Prednisolone (25 mg daily) | Recovered |
Shokraee et al. [21] | 58/female | Severe/Interferon β1 Dexamethasone Ceftriaxone | 15 /NS | Right hip | CRP: 6.5 mg/L ESR: 45 mm | N.S | N.S | NSAIDs Prednisolone (80 mg) | Recovered within 5 days |
Coath et al.[22] | 53/male | Mild/None | N.S | Sacroiliac costovertebral and costotransverse joints | CRP: 13 mg/L | NS | HLA-B27: positive | NSAIDs Methylprednisolone 120 mg | Recovered |
Danssaert et al. [23] | 37/female | Moderate/NS | 12/Negative | Wrist,MCP,IP joints/Extensor tendinosis | CRP and ESR within normal limits | RF: negative ANA: speckled | N.S | NSAIDs topical Gabapentin Opioid | Improvement without recovery |
Sinaei et al. [24] | 8/male | Mild/NS | 7/NP | Left hip | ESR: 3 mm CRP: 3.5 mg/L | RF and ANA: negative | N.S | NSAIDs | Recovered within one week |
6/female | Moderate/NS | 7/Positive | Knees, wrists, left hip | ESR = 39 mm CRP = 12 mg/L | RF and ANA: negative | N.S | NSAIDs | Recovered within 4 days | |
Jali et al. [25] | 39/female | Moderate/NS | 21/Negative | Proximal and distal IP joints of the hands | ESR and CRP within the normal range | RF, ANA and ACPA: negative | N.S | NSAIDs | Recovered |
Parisi et al. [26] | 58/female | Moderate/Paracetamol | 25/Negative | Ankle / Tendinosisof the Achilles tendon | CRP: 7.36 mg/L | RF, ANA, Antiextractable nuclear antigen, Antidouble-strand DNA: negative | N.S | NSAIDs | Clinical recovery within one month |
Di-Carlo et al. [27] | 55/male | Mild/NS | 42/NS Negative 15 days after COVID infection | Right ankle | ESR: 67 mm CRP: 5.6 mg/L | N.S | HLA-B27: negative | Steroid | Recovered |
Salvatierra J et al. [28] | 16/female | Mild/NS | 21/Negative | Dactylitis | NS | RF and ANA negative | HLA B27 negative | NSAIDs | Recovered within 5 days |
Kocyigit BF et al. [29] | 53/female | Moderate/Favipiravir Hydroxychloroquine Azithromycin | 41/NS | Knee | CRP:10.8 mg/L | RF,ACPA,ANA negative | HLA B27 negative | NSAIDs | Recovered within 10 days |
Ouedraogo F et al. [30] | 45/male | Critical/Azithromycin Ceftriaxone Hydroxychloroquine Tocilizumab | 48/Negative | Shoulders, Elbow, knee | CRP:187 mg/L ESR:136 mm/h | RF,ACPA:negative | NS | Steroid | Improvement |
Gasparotto et al. [31] | 60/male | Severe/Azithromycin CeftriaxoneHydroxychloroquine | 32/Negative | Ankle, knee, hip | CRP:237 mg/L ESR:111 mm/h | RF, ACPA, ANA:negative | HLA B27 negative | NSAIDs | Recovered within 40 days of NSAIDs Follow up of 6 months |
Apaydin H et al. [32] | 37/male | Mild/Hydroxychloroquine | 9/ Positive | Wrists, knees,ankles, elbows,MTP | CRP:117 mg/L ESR:63 mm/h | RF,ACPA,ANA: negative | HLA B27 positive | Methylprednisolone 16 mg/day | Persistant arthralgia 1 month later Initiation of Sulfasalazine |
Yokogawa N et al.[33] | 57/male | Moderate/No specific treatment | 17 / Positive | Wrist, Shoulder, the bilateral knees | CRP:48 mg/L | RF,ACPA,ANA:negative | N.S | N.S | Spontaneous reolution after 10 days |
Ghauri M et al. [34] | 34/male | Mild/AzithromycinZincMultivitamin | 16 /NS | Knee | N.S | N.S | N.S | NSAIDs IASI | Recoverd within 10 days |
Colatutto et al. [35] | 58/female | Mild/Azithromycin Hydroxychloroqine | 28/ Negative | Shoulders, Sacroiliac | Normal | ANA,RF:negative | HLA-B8 and B57 positive HLA-B27 negative | NSAIDs | Persistance of sacroiliac joint pain at 7 months |
53/female | Mild/Azithromycin Hydroxychloroqine | 15/ Negative | Sacroiliac | CRP:19 mg/L | ANA,RF:negative | N.S | NSAIDs | Recovered (9 months of follow-up) | |
El Hasbani et al. [36] | 25/male | Mild/NS | 19/ Negative | Left ankle, right elbow, low back pain, sacroiliac | CRP: 207 mg/dL | RF,ACPA,ANA:negative | HLA-B27 positive | NSAIDs Prednisolone (40 mg daily) Sulfasalazine | Improvement within 1 month |
57/male | Mild/NS | 30/ Negative | Left wrist Synovial thickening of the common extensor bursa | CRP: 28.9 mg/dL | RF,ACPA,ANA:negative | HLA-B27 positive | NSAIDs Prednisolone (30 mg daily) | Rapid improvement within 2 weeks |
RF rheumatoid factor, ACPA anti-cyclic citrullinated peptide antibodies, ANA antinuclear antibodies, NS not specified, NP not performed, MCP metacarpophalangeal joints, MTP metatarsophalangeal joints, IP interphalangeal joints, CRP C-reactive protein, ESR erythrocyte sedimentation rate, HLA human leucocyte antigen, NSAIDs non steroidal anti inflammatory drugs, IASIintra articular steroid injection
aSymptoms of COVID-19 infection were collected and severity was classified as: asymptomatic, mild, moderate, severe, and critical